IFP Advisors’s FibroBiologics FBLG Stock Holding History

IFP Advisors’s Portfolio FBLG Stock Details FBLG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$35.1K	Buy	+27,000	New	+$31.5K	﹤0.01%	2609
2025 Q4	–	Hold	0	–	-$1	–	5060
2025 Q3	–	Hold	0	–	–	–	4830
2025 Q2	–	Hold	0	–	–	–	4908
2025 Q1	–	Hold	0	–	-$2	–	4674
2024 Q4	–	Hold	0	–	–	–	4584

Other funds holding FBLG

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Grove Bank & Trust Miami, Florida $1.01B AUM 19.76% 1-Year Est. Return

Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return

Allworth Financial Folsom, California $28.2B AUM 13.34% 1-Year Est. Return

Citigroup New York $308B AUM 40.94% 1-Year Est. Return

IFP Advisors's FBLG Position: Q3 2026 in Review

IFP Advisors opened a new position in FibroBiologics (FBLG) in Q3 2026: 27,000 shares worth $35.1K. The stake represents ﹤0.01% of the portfolio and ranks #2609 among its holdings.

6 funds tracked by Wall St. Rank hold FBLG as of Q3 2026.

IFP Advisors held 27,000 shares of FibroBiologics worth $35.1K as of Q3 2026.
FibroBiologics was a new IFP Advisors position in Q3 2026.
FibroBiologics made up ﹤0.01% of IFP Advisors's portfolio in Q3 2026, its #2609 holding.
6 funds tracked by Wall St. Rank held FibroBiologics as of Q3 2026.

Based on IFP Advisors's 13F filing for Q3 2026, filed 16 Oct 2026.